Wei-Chien Yuan

1.5k citations
9 papers · 1.1k indexed · h-index 9
Topics
Ubiquitin and proteasome pathways (5 papers)Hippo pathway signaling and YAP/TAZ (3 papers)Cancer, Hypoxia, and Metabolism (2 papers)
Partner nations
United StatesTaiwanItaly

In The Last Decade

Wei-Chien Yuan

9 papers receiving 1.1k citations

Peers

Wei-Chien Yuan
Comparison fields: 5 of 76
  • Molecular Biology 821
  • Cell Biology 407
  • Oncology 200
  • Cancer Research 161
  • Epidemiology 107
Replace Emma Sandilands with:
Emma Sandilands United Kingdom
Ai Kaiho Japan
Hauke Cornils Switzerland
Antonio Castro-Castro France
Colin E.J. Pritchard Netherlands
Julian Jude Austria
Guillaume Bompard France
Antonio Marzio United States
Jarkko Ylanko Canada
Sarah Bowling United States
Wei-Chien Yuan relative to Emma Sandilands United Kingdom Emma Sandilands's profile →
Citations per field
00.5×3.1×
Emma Sandilands · 1×
Citations per year

Countries citing papers authored by Wei-Chien Yuan

Since Specialization
Citations

This map shows the geographic impact of Wei-Chien Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Chien Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Chien Yuan more than expected).

Fields of papers citing papers by Wei-Chien Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei-Chien Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Chien Yuan. The network helps show where Wei-Chien Yuan may publish in the future.

Co-authorship network of co-authors of Wei-Chien Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Wei-Chien Yuan. A scholar is included among the top collaborators of Wei-Chien Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei-Chien Yuan. Wei-Chien Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 194
2 125
3 103
4 201
5 50
6 132
7 31
8 149
9 102

About Wei-Chien Yuan

Wei-Chien Yuan is a scholar working on Cell Biology, Cancer Research and Biochemistry, having authored 9 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Hippo pathway signaling and YAP/TAZ (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cell Biology (407 citations), Molecular Biology (821 citations) and Cancer Research (161 citations). Wei-Chien Yuan has collaborated with scholars based in United States, Taiwan and Italy. Frequent co-authors include Fernando D. Camargo, Ruey‐Hwa Chen, Yu-Ru Lee, Raffaele Calogero, Giorgio Giacomo Galli, Brian J. Pepe-Mooney, Fernando G. Osorio, Priscilla Cheung, Michael T. Dill and Chun-Hau Chen. Their work appears in journals such as Cell, Nature Communications and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026